(Q42234623)

19 October 2017

The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm (English)

1 reference

19 October 2017

1 reference

1 reference

1 reference

7

Torsten Haferlach

1 reference

19 October 2017

3

Manja Meggendorfer

1 reference

19 October 2017

13

Georgia Metzgeroth

1 reference

19 October 2017

9

Alice Fabarius

1 reference

19 October 2017

6

Karl Sotlar

1 reference

19 October 2017

5

Hans-Peter Horny

1 reference

19 October 2017

2

Juliana Schwaab

1 reference

19 October 2017

11

Wolf-Karsten Hofmann

1 reference

19 October 2017

4

Nicole Naumann

1 reference

19 October 2017

Mohamad Jawhar

1

1 reference

19 October 2017

Karla Schmitt

8

1 reference

19 October 2017

Peter Valent

10

1 reference

19 October 2017

Nicholas C P Cross

12

1 reference

19 October 2017

Andreas Reiter

14

1 reference

19 October 2017

2 March 2017

1 reference

19 October 2017

1 reference

19 October 2017

102

1 reference

19 October 2017

6

1 reference

19 October 2017

1035-1043

1 reference

Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V( ) advanced systemic mastocytosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Mast Cells, Mastocytosis, and Related Disorders

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Diagnostic criteria and classification of mastocytosis: a consensus proposal

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Comprehensive mutational profiling in advanced systemic mastocytosis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Cladribine therapy for systemic mastocytosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5451335

Mast cell leukemia: a report of ten cases

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28255023

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28255023

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28255023

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3324/HAEMATOL.2017.163964

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

28255023

1 reference